The first comprehensive single-cell atlas of human teeth – Newswise
stemadminStem Cell ResearchNo comments

Newswise During the last 30 years, medical and dental research has attracted a large number of scientists and practitioners working on aspects of high medical relevance that involve a combination of genetic and tissue regeneration approaches. These developments in stem cell and tissue engineering have provided medical and dental researchers with new insights and given rise to new ideas as to how everyday clinical practice can be improved. Many research groups are dealing with questions like: How can we help injured tissues and organs heal

Read more
Rocket Pharmaceuticals Announces Upcoming Clinical Data Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy -…
stemadminStem Cell ResearchNo comments

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces clinical data presentations at the upcoming 24thAmerican Society of Gene and Cell Therapy (ASGCT) Annual Meeting taking place May 11-14, 2021. Investigators will review new data from Rockets Leukocyte Adhesion Deficiency-I (LAD-I), Pyruvate Kinase Deficiency (PKD), and Fanconi Anemia (FA) gene therapy programs in oral and poster presentations.

Read more
Adipose Tissue-Derived Stem Cells (ADSCS) Market Value with Volume and Growth Prospects 2021 to 2027 The Courier – The Courier
stemadminStem Cell ResearchNo comments

The latest report on Adipose Tissue-Derived Stem Cells (ADSCS) market report emphasizes on key market dynamics of industry and covers historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Adipose Tissue-Derived Stem Cells (ADSCS) market research report proves to be a precious source of information with which businesses can achieve a telescopic view of the current market trends, consumers demands and preferences, market situations, opportunities and market status. All the data, figures and information is backed up by well recognized analysis tools which include SWOT analysis and Porters Five Forces analysis

Read more
Placental-derived stem cell therapy shows promise to heal intestinal disease in premature babies – News-Medical.Net
stemadminStem Cell ResearchNo comments

An intestinal bowel disease that affects up to 10 percent of premature infants at a very vulnerable and developmentally crucial time can lead to serious infection and death. Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) are tackling the disease with a human placental-derived stem cell (hPSC) therapy strategy that is showing promising results

Read more
Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030 – Yahoo Finance
stemadminStem Cell ResearchNo comments

Major players in the stem cell therapy market are Anterogen, JCR Pharmaceuticals, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, and Gamida Cell. New York, April 27, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030" - https://www.reportlinker.com/p06064499/?utm_source=GNW The global stem cell therapy market is expected to grow from $8.62 billion in 2020 to $10.2 billion in 2021 at a compound annual growth rate (CAGR) of 18.3%.

Read more
Poseida Therapeutics to Present at American Society of Gene and Cell Therapy 2021 Annual Meeting – PRNewswire
stemadminStem Cell ResearchNo comments

SAN DIEGO, April 27, 2021 /PRNewswire/ --Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced three data presentations to be delivered at the upcoming American Society of Gene and Cell Therapy (ASGCT) 24th Annual Meeting, being held virtually May 11-14, 2021. Poseida will present the following research at the 2021 ASGCT Annual Meeting: Oral Presentation Title: Preclinical Evaluation of Combined Adeno-Associated Virus and Nanoparticle Delivery of piggyBac Transposon System for Durable Transgene Expression in the Growing Neonatal Murine Liver Session Date/Time:Tuesday, May 11, 2021, 5:45pm - 6:00pm ETAbstract Number:30 Poster PresentationsTitle: P-BCMA-ALLO1 A Fully Allogeneic Stem Cell Memory T Cell (TSCM) CAR-T Therapy Targeting BCMA for the Treatment of Multiple Myeloma Shows Potent Anti-Tumor ActivitySession Date/Time: Tuesday, May 11, 2021, 8:00am 10:00am ETAbstract Number: 789 Title: Anti-c-kit CAR-T Cells Afford Effective Eradication of Human AML and Normal Hematopoietic Cells in a Preclinical Model of Safer Non-Genotoxic Stem Cell Transplant Conditioning Session Date/Time: Tuesday, May 11, 2021, 8:00am 10:00am ETAbstract Number: 715 About Poseida Therapeutics, Inc.Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing our proprietary genetic engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure.

Read more

Theme: Illdy.